← Leaderboards
Jing Wang
Augusta University
$1,155,000
Attributed
$1,155,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $385K · FY2023–25$500K$375K$250K$125K$0
'23
'24
'25
Funding mix
By agency
NIH$1,155,000 · 1
By mechanism
R01$1,155,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Augusta University
Same institution · by research overlap
- Ruth B. Caldwell$11,181,117
- Kathryn Bollinger$3,842,872
- Masuko Ushio-Fukai$11,852,733
- Tohru Fukai$10,473,455
- Balamurali K Ambati$10,199,905
Others in their field
Other Rising Stars on “Affect”
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Thomas K Karikari · Wake Forest University Health Sciences$14,340,584
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Brian Todd Schaneberg · Illinois Institute Of Technology$13,469,813
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
Research focus
AffectAutomobile DrivingBevacizumabBlindnessBlood VesselsCell InjuryCell ProliferationCellsCell SurvivalCell TypeCharacteristicsChildhoodCoculture TechniquesConditional KnockoutContrast SensitivityDesignDeteriorationDiabetic RetinopathyDropsElectroretinographyElementsEndothelial CellsEnvironmentAcceleration
Grant awards (3)
Targeting Sigma 1 receptor as a novel therapy for limiting neurovascular injury in ROP$385,000
R01 · FY2025 · EY · contact PI
Targeting Sigma 1 receptor as a novel therapy for limiting neurovascular injury in ROP$385,000
R01 · FY2024 · EY · contact PI
Targeting Sigma 1 receptor as a novel therapy for limiting neurovascular injury in ROP$385,000
R01 · FY2023 · EY · contact PI